An experimental technology developed by Stanford Medicine bioengineers saves the life of a precious racehorse with big-league dreams.
Emergence comprises some 100 experts, serving as speakers, advisors or mentors, that guide how to identify societal needs and carry out the entrepreneurial process.
Biodesign program trains global fellows to take what they learn about technological innovation back home to train others.
Stanford Medicine's Catalyst program, which aims to accelerate impactful health care innovations, launches a new cohort.
Brain tumors are among the most deadly and difficult-to-treat cancers. Glioblastoma, a particularly aggressive form, kills more than 10,000 Americans a year and has a …
Bioengineer Alison Marsden uses computer modeling skills honed on submarines to help surgeons plan the best repairs for babies' hearts.
Stanford researchers are building a heart through tissue engineering techniques in the hopes of better treating congenital heart defects.
Scientists have devised a wearable sleeve that helps communicate physical touch from afar, a concept dubbed "haptic communication."
A Stanford Medicine bioengineer sets out to create a world fueled by synthetic biology, creating tools and technologies to see it through.
Researchers have found that a phenomenon tied to animal size helps determine whether animals heal without scarring after burn injury.
This new issue of Stanford Medicine magazine explores scientific advances that are helping unlock the mysteries of the brain.
To help us understand muscle loss as we age, a Stanford Medicine research team’s engineered tissue is sent to the International Space Station.
Tracking a pain-relief device's success in patients who aren't in clinical trials is seen as a promising approach to expanding treatment options for kids.
Technology that sends blood sugar-level updates to their smartphones improves outcomes for young people with type 1 diabetes, a Stanford trial shows.
The 2020 Nobel Prize in Chemistry recognized the scientists who developed the CRISPR-Cas9 gene-editing technology. Here's how it's changing medicine.
A team of Stanford undergraduates designed a device that uses blue-light imaging technology to diagnose a parasitic disease called river blindness.
